Showing results (3301-3310 of 5,923) with videos related to

Sort By:
Pageof 593
Arthritis Research & Therapy|February 2, 2019
Upregulation of miR-107 expression following hyperbaric oxygen treatment suppresses HMGB1/RAGE signaling in degenerated human nucleus pulposus cellsChi-Chien Niu, Song-Shu Lin, Li-Jen Yuan, et al.
Arthritis Research & Therapy|January 13, 2019
Impairment of glyoxalase-1, an advanced glycation end-product detoxifying enzyme, induced by inflammation in age-related osteoarthritisSabine Trellu, Alice Courties, Stéphane Jaisson, et al.
Arthritis Research & Therapy|January 13, 2019
Vitamin D protects podocytes from autoantibodies induced injury in lupus nephritis by reducing aberrant autophagyQi Yu, Yingjin Qiao, Dongwei Liu, et al.
Arthritis Research & Therapy|February 8, 2019
Microbiome dysbiosis is associated with disease duration and increased inflammatory gene expression in systemic sclerosis skinMichael E Johnson, Jennifer M Franks, Guoshuai Cai, et al.
Arthritis Research & Therapy|February 8, 2019
New-onset non-infectious pulmonary manifestations among patients with systemic lupus erythematosus in SwedenLindsy J Forbess, Marios Rossides, Michael H Weisman, et al.
Arthritis Research & Therapy|December 18, 2019
Performance of cytokine models in predicting SLE activityNopparat Ruchakorn, Pintip Ngamjanyaporn, Thanitta Suangtamai, et al.
Arthritis Research & Therapy|December 18, 2019
DZ2002 ameliorates fibrosis, inflammation, and vasculopathy in experimental systemic sclerosis modelsZongwang Zhang, Yanwei Wu, Bing Wu, et al.
Arthritis Research & Therapy|December 21, 2019
Integrated systems analysis of salivary gland transcriptomics reveals key molecular networks in Sjögren's syndromeHong Ki Min, Su-Jin Moon, Kyung-Su Park, et al.
Arthritis Research & Therapy|December 14, 2019
Is 18F-FDG PET/CT useful for diagnosing relapsing polychondritis with airway involvement and monitoring response to steroid-based therapy?Yunxiang Zeng, Minfang Li, Sheng Chen, et al.
Arthritis Research & Therapy|December 14, 2019
FKB327, an adalimumab biosimilar, versus the reference product: results of a randomized, Phase III, double-blind study, and its open-label extensionMark C Genovese, Josephine Glover, Maria Greenwald, et al.
Pageof 593